One could speculate that a key treatment strategy for progressive MS could involve targeting CNS-resident B cells, not aiming to suppress their traditional immunological (mis)behavior, but instead to quell a yet-to-be-discovered unconventional action, possibly related to secretion of an MS-specific myelin toxin into the CSF
BPC-157 dosages up to 500 mcg/kg are well-tolerated by rodents in clinical research, indicating the peptides low toxicity (7)
Supporting Cellular Glutathione Production Because glutathione works inside cells, researchers continue to study nutrients and precursor compounds that may support natural glutathione production
Li O, Ma Q, Li F, Cai GY, Chen XM, Hong Q
Anlacan VM, Lanuza PD, Sanchez AA, Jamora RD (2024) Current status and challenges in dementia care in the Philippines: a scoping review